NASC
Nascent Pharma Holdings, Inc.
Price Chart
Latest Quote
$0.01
+0.00 (+0.00%)
Current Price
| Previous Close | $0.01 |
| Open | $0.01 |
| Day High | $0.01 |
| Day Low | $0.01 |
| Volume | 13,778 |
Stock Information
| Shares Outstanding | 90.22M |
| Total Debt | $9.01M |
| Cash Equivalents | $8K |
| Revenue | $1.03M |
| Net Income | $-13.26M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $1.17M |
| P/E Ratio | 0.14 |
| EPS (TTM) | $0.09 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $18.20M |
| Sales | $1.03M |
| Income | $-13.26M |
| Book/sh | $-0.26 |
| Cash/sh | $0.00 |
| Employees | 12 |
Financial Ratios
| Quick Ratio | 0.12 |
| Current Ratio | 0.14 |
Returns & Margins
| ROA | -62.52% |
| Gross Margin | -33.22% |
| Operating Margin | -18553.67% |
Ownership
| Institutional Ownership | 0.16% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 1.13 |
| P/B | -0.05 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.01 |
| SMA50 | $0.01 |
| SMA200 | $0.02 |
| RSI | 16.67 |
| ATR | 0.0007 |
| Shares Float | 73.55M |
| Volatility | 0.78 |
| Rel Volume | 0.44 |
Performance History
| Week | +0.00% |
| Month | -13.33% |
| Quarter | -31.58% |
| 6 Months | -35.00% |
| YTD | -13.33% |
| Year | -27.78% |
| 3 Years | -96.75% |
| 5 Years | -99.81% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $0.01 | 13,800 |
| 2026-06-22 | $0.01 | 0 |
| 2026-06-18 | $0.01 | 24,000 |
| 2026-06-17 | $0.01 | 0 |
| 2026-06-16 | $0.01 | 10,000 |
| 2026-06-15 | $0.01 | 1,000 |
| 2026-06-12 | $0.01 | 148,700 |
| 2026-06-11 | $0.01 | 205,000 |
| 2026-06-10 | $0.01 | 0 |
| 2026-06-09 | $0.01 | 30,500 |
| 2026-06-08 | $0.02 | 0 |
| 2026-06-05 | $0.02 | 0 |
| 2026-06-04 | $0.02 | 17,000 |
| 2026-06-03 | $0.02 | 63,200 |
| 2026-06-02 | $0.02 | 0 |
| 2026-06-01 | $0.02 | 3,900 |
| 2026-05-29 | $0.01 | 0 |
| 2026-05-28 | $0.01 | 59,400 |
| 2026-05-27 | $0.01 | 55,000 |
| 2026-05-26 | $0.01 | 1,000 |
About Nascent Pharma Holdings, Inc.
Nascent Pharma Holdings, Inc. engages in the protection and commercialization of cannabis patents. It produces superfood drink mix products under the Longevity brand name. The company was formerly known as Can B Corp. and changed its name to Nascent Pharma Holdings, Inc. in September 2025. Nascent Pharma Holdings, Inc. was incorporated in 2005 and is based in Hicksville, New York.
đ° Latest News
No news articles available at the moment. Check back later for updates on NASC.
Period:
Loading...
Income Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $1,797,047 | $4,071,144 | $1,611,730 |
| Cost Of Revenue | $1,797,047 | $4,071,144 | $1,611,730 |
| Total Revenue | $2,155,744 | $6,685,519 | $4,603,829 |
| Operating Revenue | $2,155,744 | $6,685,519 | $4,603,829 |
| Expenses | |||
| Interest Expense | $2,510,811 | $902,130 | $2,102,193 |
| Total Expenses | $9,642,187 | $20,853,666 | $14,869,836 |
| Other Income Expense | $269,385 | $146,895 | $199,880 |
| Other Non Operating Income Expenses | $68,108 | $-7,115 | $2,991 |
| Net Non Operating Interest Income Expense | $-2,510,811 | $-902,130 | $-2,102,193 |
| Interest Expense Non Operating | $2,510,811 | $902,130 | $2,102,193 |
| Operating Expense | $7,845,140 | $16,782,522 | $13,258,106 |
| Other Operating Expenses | $3,096,330 | $4,167,301 | $3,616,897 |
| General And Administrative Expense | $4,748,810 | $12,615,221 | $9,641,209 |
| Rent Expense Supplemental | - | $926,696 | $675,310 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-9,737,464 | $-14,924,175 | $-12,169,395 |
| Net Interest Income | $-2,510,811 | $-902,130 | $-2,102,193 |
| Normalized Income | $-9,896,473 | $-15,045,843 | $-12,313,124 |
| Net Income From Continuing And Discontinued Operation | $-9,737,464 | $-14,924,175 | $-12,169,395 |
| Total Operating Income As Reported | $-7,486,442 | $-14,168,147 | $-10,266,007 |
| Net Income Common Stockholders | $-9,737,464 | $-14,924,175 | $-12,169,395 |
| Net Income | $-9,737,464 | $-14,924,175 | $-12,169,395 |
| Net Income Including Noncontrolling Interests | $-9,737,464 | $-14,924,175 | $-12,169,395 |
| Net Income Continuous Operations | $-9,737,464 | $-14,924,175 | $-12,169,395 |
| Pretax Income | $-9,727,868 | $-14,923,382 | $-12,168,320 |
| Operating Income | $-7,486,442 | $-14,168,147 | $-10,266,007 |
| Gross Profit | $358,698 | $2,614,375 | $2,992,099 |
| Special Income Charges | - | $0 | $196,889 |
| Per Share | |||
| Diluted EPS | $-0.77 | $-4.18 | $-9.06 |
| Basic EPS | $-0.77 | $-4.18 | $-9.06 |
| Other | |||
| Tax Effect Of Unusual Items | $42,268 | $32,342 | $53,160 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-6,018,385 | $-12,740,295 | $-9,720,671 |
| Total Unusual Items | $201,277 | $154,010 | $196,889 |
| Total Unusual Items Excluding Goodwill | $201,277 | $154,010 | $196,889 |
| Reconciled Depreciation | $1,399,949 | $1,434,967 | $542,345 |
| EBITDA (Bullshit earnings) | $-5,817,108 | $-12,586,285 | $-9,523,782 |
| EBIT | $-7,217,057 | $-14,021,252 | $-10,066,127 |
| Diluted Average Shares | $12,590,147 | $3,570,087 | $1,343,219 |
| Basic Average Shares | $12,590,147 | $3,570,087 | $1,343,219 |
| Diluted NI Availto Com Stockholders | $-9,737,464 | $-14,924,175 | $-12,169,395 |
| Tax Provision | $9,596 | $793 | $1,075 |
| Gain On Sale Of Security | $201,277 | $154,010 | - |
| Selling General And Administration | $4,748,810 | $12,615,221 | $9,641,209 |
| Other Gand A | $1,824,952 | $5,416,006 | $3,968,744 |
| Salaries And Wages | $2,923,858 | $7,199,215 | $4,997,155 |
| Rent And Landing Fees | - | $926,696 | $675,310 |
| Other Special Charges | - | - | $-196,889 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $-1,097,112 | $2,590,781 | $5,250,500 |
| Total Assets | $10,126,164 | $15,559,791 | $16,474,640 |
| Total Non Current Assets | $4,745,135 | $6,855,310 | $9,821,004 |
| Other Non Current Assets | $13,139 | $13,139 | $13,139 |
| Non Current Prepaid Assets | $235,418 | $165,787 | $165,787 |
| Goodwill And Other Intangible Assets | $95,144 | $107,144 | $369,015 |
| Other Intangible Assets | $95,144 | $107,144 | $369,015 |
| Current Assets | $5,381,029 | $8,704,481 | $6,653,639 |
| Other Current Assets | $4,137 | $21,024 | $4,523 |
| Inventory | $1,619,542 | $2,024,053 | $2,553,438 |
| Receivables | $3,723,344 | $6,586,210 | $3,646,677 |
| Accounts Receivable | $3,723,344 | $6,586,210 | $3,646,677 |
| Allowance For Doubtful Accounts Receivable | $-2,818,395 | $-985,028 | $-547,241 |
| Gross Accounts Receivable | $6,541,739 | $7,571,238 | $4,193,918 |
| Cash Cash Equivalents And Short Term Investments | $34,006 | $73,194 | $449,001 |
| Cash And Cash Equivalents | $34,006 | $73,194 | $449,001 |
| Prepaid Assets | - | - | $1,625 |
| Notes Receivable | - | - | $2,898 |
| Debt | |||
| Net Debt | $8,892,726 | $8,173,245 | $4,635,021 |
| Total Debt | $9,181,123 | $9,336,715 | $7,284,313 |
| Long Term Debt And Capital Lease Obligation | $0 | $438,104 | $1,392,068 |
| Current Debt And Capital Lease Obligation | $9,181,123 | $8,898,611 | $5,892,245 |
| Current Debt | $8,926,732 | $8,246,439 | $5,084,022 |
| Other Current Borrowings | $8,569,489 | $7,951,196 | $4,865,749 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $11,128,132 | $12,861,866 | $10,855,125 |
| Total Non Current Liabilities Net Minority Interest | $0 | $438,104 | $1,392,068 |
| Current Liabilities | $11,128,132 | $12,423,762 | $9,463,057 |
| Other Current Liabilities | $1,766 | $203,043 | - |
| Current Notes Payable | $8,926,732 | $8,246,439 | $5,084,022 |
| Payables And Accrued Expenses | $1,945,243 | $3,322,108 | $3,570,812 |
| Payables | $1,945,243 | $3,140,408 | $1,163,284 |
| Accounts Payable | $1,945,243 | $3,140,408 | $1,163,284 |
| Equity | |||
| Common Stock Equity | $-9,222,011 | $-5,522,118 | $-23,027,487 |
| Preferred Stock Equity | $8,220,043 | $8,220,043 | $28,647,002 |
| Total Equity Gross Minority Interest | $-1,001,968 | $2,697,925 | $5,619,515 |
| Stockholders Equity | $-1,001,968 | $2,697,925 | $5,619,515 |
| Retained Earnings | $-102,428,298 | $-92,690,834 | $-77,766,659 |
| Other Equity Interest | - | $119,586 | - |
| Other | |||
| Treasury Shares Number | $36,248 | $36,248 | - |
| Ordinary Shares Number | $32,716,948 | $4,386,336 | $2,834,755 |
| Share Issued | $32,753,196 | $4,422,584 | $2,834,755 |
| Tangible Book Value | $-9,317,155 | $-5,629,262 | $-23,396,502 |
| Invested Capital | $-295,279 | $2,724,321 | $-17,943,465 |
| Working Capital | $-5,747,103 | $-3,719,281 | $-2,809,418 |
| Capital Lease Obligations | $254,391 | $1,090,276 | $2,200,291 |
| Total Capitalization | $-1,001,968 | $2,697,925 | $5,619,515 |
| Treasury Stock | $572,678 | $572,678 | $572,678 |
| Additional Paid In Capital | $10,396,274 | $8,006,822 | $5,635,003 |
| Capital Stock | $91,602,734 | $87,954,615 | $78,323,849 |
| Common Stock | $83,382,691 | $79,734,572 | $49,676,847 |
| Preferred Stock | $8,220,043 | $8,220,043 | $28,647,002 |
| Long Term Capital Lease Obligation | $0 | $438,104 | $1,392,068 |
| Current Capital Lease Obligation | $254,391 | $652,172 | $808,223 |
| Current Accrued Expenses | $0 | $181,700 | $2,407,528 |
| Dueto Related Parties Current | $357,243 | $295,243 | $218,273 |
| Net PPE | $4,401,434 | $6,569,240 | $9,273,063 |
| Accumulated Depreciation | $-3,559,200 | $-2,171,251 | $-802,996 |
| Gross PPE | $7,960,634 | $8,740,491 | $10,076,059 |
| Leases | $26,902 | $26,902 | $26,902 |
| Other Properties | $7,899,630 | $8,679,487 | $10,015,052 |
| Machinery Furniture Equipment | $34,102 | $34,102 | $34,105 |
| Properties | $0 | $0 | $0 |
| Finished Goods | $423,430 | $1,194,209 | $1,735,396 |
| Raw Materials | $1,196,112 | $829,844 | $818,042 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-1,319,495 | $-3,947,424 | $-8,183,525 |
| Operating Activities | |||
| Operating Cash Flow | $-1,304,495 | $-3,947,424 | $-7,467,232 |
| Cash Flow From Continuing Operating Activities | $-1,304,495 | $-3,947,424 | $-7,467,232 |
| Operating Gains Losses | $-311,277 | $154,990 | $-196,889 |
| Investing Activities | |||
| Capital Expenditure | $-15,000 | - | $-716,293 |
| Investing Cash Flow | $-84,631 | $0 | $-716,293 |
| Cash Flow From Continuing Investing Activities | $-84,631 | $0 | $-716,293 |
| Net Other Investing Changes | $-69,631 | - | $-144,500 |
| Financing Activities | |||
| Repurchase Of Capital Stock | $0 | $0 | $0 |
| Issuance Of Capital Stock | $0 | $500,000 | $6,555,455 |
| Financing Cash Flow | $1,349,938 | $3,571,617 | $8,174,728 |
| Cash Flow From Continuing Financing Activities | $1,349,938 | $3,571,617 | $8,174,728 |
| Net Other Financing Charges | $-116,000 | $-736 | $218,273 |
| Net Preferred Stock Issuance | $0 | $0 | $2 |
| Preferred Stock Issuance | $0 | $0 | $2 |
| Net Common Stock Issuance | $0 | $500,000 | $6,555,453 |
| Common Stock Issuance | $0 | $500,000 | $6,555,453 |
| Other | |||
| Repayment Of Debt | $-939,062 | $-377,500 | $-224,000 |
| Issuance Of Debt | $2,405,000 | $3,449,853 | $1,625,000 |
| Interest Paid Supplemental Data | $0 | $83,147 | $4,000 |
| Income Tax Paid Supplemental Data | $0 | $1,075 | $1,075 |
| End Cash Position | $34,006 | $73,194 | $449,001 |
| Beginning Cash Position | $73,194 | $449,001 | $457,798 |
| Changes In Cash | $-39,188 | $-375,807 | $-8,797 |
| Common Stock Payments | $0 | $0 | $0 |
| Net Issuance Payments Of Debt | $1,465,938 | $3,072,353 | $1,401,000 |
| Net Long Term Debt Issuance | $1,465,938 | $3,072,353 | $1,401,000 |
| Long Term Debt Payments | $-939,062 | $-377,500 | $-224,000 |
| Long Term Debt Issuance | $2,405,000 | $3,449,853 | $1,625,000 |
| Net PPE Purchase And Sale | $-15,000 | $0 | $-538,763 |
| Purchase Of PPE | $-15,000 | $0 | $-538,763 |
| Change In Working Capital | $677,340 | $-1,689,393 | $-2,596,328 |
| Change In Other Current Assets | $5,847 | $-26,764 | $-13,491 |
| Change In Payables And Accrued Expense | $-954,904 | $1,512,871 | $1,466,677 |
| Change In Accrued Expense | $0 | $-475,828 | $457,033 |
| Change In Payable | $-954,904 | $1,988,699 | $1,009,644 |
| Change In Account Payable | $-954,904 | $1,988,699 | $1,009,644 |
| Change In Prepaid Assets | $16,887 | $-14,327 | $-136,024 |
| Change In Inventory | $580,011 | $529,385 | $-2,208,484 |
| Change In Receivables | $1,029,499 | $-3,690,558 | $-1,705,006 |
| Changes In Account Receivables | $1,029,499 | $-3,690,558 | $-1,705,006 |
| Other Non Cash Items | $3,381,925 | $5,007,840 | $4,496,604 |
| Stock Based Compensation | $1,451,665 | $5,064,860 | $2,395,038 |
| Asset Impairment Charge | $1,833,367 | $1,003,487 | $61,393 |
| Depreciation Amortization Depletion | $1,399,949 | $1,434,967 | $542,345 |
| Depreciation And Amortization | $1,399,949 | $1,434,967 | $542,345 |
| Amortization Cash Flow | $12,000 | $26,906 | $48,689 |
| Amortization Of Intangibles | $12,000 | $26,906 | $48,689 |
| Depreciation | $1,387,949 | $1,408,061 | $493,656 |
| Gain Loss On Investment Securities | $-201,277 | $-154,010 | - |
| Gain Loss On Sale Of PPE | $0 | $309,000 | $0 |
| Net Income From Continuing Operations | $-9,737,464 | $-14,924,175 | $-12,169,395 |
| Net Intangibles Purchase And Sale | - | $0 | $-177,530 |
| Purchase Of Intangibles | - | $0 | $-177,530 |
Fetched: 2026-02-02